Status:
COMPLETED
Allo BMT in Advanced Leukemia or High Grade Lymphoma
Lead Sponsor:
Stanford University
Conditions:
Lymphoma, Non-Hodgkin
Leukemia
Eligibility:
All Genders
Up to 50 years
Phase:
NA
Brief Summary
To evaluate the role of ablative allogeneic hematopoietic cell transplantation in the treatment of advanced leukemia or lymphoma.
Detailed Description
To determine the disease free survival and overall survival of patients with ALL and ANLL after induction failure, in relapse, or subsequent remission from CML in several phases or recurrent lymphobla...
Eligibility Criteria
Inclusion
- Inclusion Criteria:HLA identical donor
- adequate organ function
- other life threatening disease
Exclusion
Key Trial Info
Start Date :
December 1 1989
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2009
Estimated Enrollment :
145 Patients enrolled
Trial Details
Trial ID
NCT00186290
Start Date
December 1 1989
End Date
October 1 2009
Last Update
October 11 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford University School of Medicine
Stanford, California, United States, 94305